Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What do they want from XCHC and CBIS?
money? products? jail?
confused?
GO where?
?
history?
we will see what happen.
good luck
$0.05 end of this week?
MMs are loading
Go gben
if you know sth, why don't you share it with us?
who is responsible for the 10Q? Dr. Bob, or new CEO, or Kane?
Xchc released its on 6/5/2013, believed as the sister. Company of CBIS.
How long will the new CEO take to create her first own PR?
CBIS needs the final trigger, next week?
GO CBIS
Any news from the movie?
GO CBIS!
Believe or not, cbis coming run wave will be huge, very soon!
Loading or selling up to your own decision.
Smart money for your reward!
GO CBIS!
Will the next PR be conservative from a new CEO?
If you cannot make money from CBIS, I am sorry for you.
GO CBIS
D-Day in Europe!
now a good opportunity for cbis
new ceo bring new management and development in Europe
more attention on the cancer treatment from public
divy will solve the financial
a run will be here next week
D-day for Europe
go cbis
Kane destroy two companies!
Kane, PR machine, was stopped by Dr. Bray!
MMs are loading without hurry
GO CBIS
huge volume!!!
GO CBIS!
What is the leadership between Dr. Bray and Mr. Kane?
Kane moved phytiva to XCHC, could Dr. Bray stop Kane` other activities between CBIS and XCHC? or they do it together?
CBIS is #16 hot board
GO CBIS
$0.3~0.4!!!
CBIS running!
New CEO, HIV, Movie, etc....
the most important things are:
hire a CFO
change the Vice President of Investor Relations
?
What is the role of CEO?
Can the CEO make major decision?
Dr. Robert Melamede has more power than CEO?
cbis officers are becoming younger and younger
Will a newly appointed official work hard to show her efficiency?
cancer treatment
http://abclocal.go.com/kgo/story?section=news/health&id=9057615
more from mjn* today pr
look like more marijuana company will focus on cancer treatment
definitely, lol
Why does the person sell the 1,318,000 shares at $0.0403 after hour, not at $0.045 regular time?
lose around $6000
Crazy?
CBIS will be over $0.20 again around 6/6
No PRs in May
Cbis change PRs release pattern?
When the issued shares reach Authorized Shares, what will MJNA do, reverse split or increase Authorized Shares?
cbis product new names
CS-TATI-I for HIV-associated Kaposi's Sarcoma
CS-S/BCC-1 for basal and squamous cell carcinomas
phytiva is the bypass product for xchc
right?
Kane: too clever to be wise
Why do I need to show you something?
I will definitely not make any decisions according to your posts here.
Again, we will see.
we will see what will happen
Once again, CBIS will perform the clinical trails to confirm it.
We all know that there is not any panacea in the world.
If you think so, you are right!
haha, if the effect has been confirmed in human body, the clinical trails is not necessary to perform, is it?
effect in vitro, effect in animal, and then confirmed in human body, that is purpose of clinical trails
Marijuana is a good medicine for PSTD!
CBIS corporate with Echo Pharmaceuticals and Farmalyse in Amsterdam Biomed Cluster?
Echo Pharmaceuticals is a privately owned and rapidly growing specialized pharmaceutical company based in The Netherlands, founded in 2006. Our mission is to develop effective medicines, with a focus on cannabinoid-based compounds, and drug delivery technologies that contribute to better the quality of life for a wide range of patients. In 2009, we established our headquarters and clinical research center in Nijmegen, which is situated in an area of the Netherlands well-known for its ideal environment for businesses in life sciences and health.
Bactimm B.V. & Farmalyse B.V. offers contract services for the pharmaceutical, medical devices, cosmetics industry and hospitals, with dedicated centres of excellence for Microbiological and Pharma-Chemical Investigations.
Bactimm and Farmalyse are your partners for analytical services, laboratory investigations & international services that are customised to the requirements of the industry
Cannabis Science cure cancer
extract source
extract method
application on patients with different types of cancers
data analysis
improvement
product standard
....
cannabis cure cancer more
http://www.ncbi.nlm.nih.gov/pubmed/?term=cannabis+cancer
cannabis cure cancer 2
Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.
Cannabidiol (CBD), a major non-psychotropic constituent of fiber-type cannabis plant, has been reported to possess diverse biological activities, including anti-proliferative effect on cancer cells. Although CBD is obtained from non-enzymatic decarboxylation of its parent molecule, cannabidiolic acid (CBDA), few studies have investigated whether CBDA itself is biologically active. Results of the current investigation revealed that CBDA inhibits migration of the highly invasive MDA-MB-231 human breast cancer cells, apparently through a mechanism involving inhibition of cAMP-dependent protein kinase A, coupled with an activation of the small GTPase, RhoA. It is established that activation of the RhoA signaling pathway leads to inhibition of the mobility of various cancer cells, including MDA-MB-231 cells. The data presented in this report suggest for the first time that as an active component in the cannabis plant, CBDA offers potential therapeutic modality in the abrogation of cancer cell migration, including aggressive breast cancers.